The clinical trial for INS115644 (latrunculin B; Inspire Pharmaceuticals) for safety and elevated intraocular pressure in glaucoma was completed September 9, 2009 (clinical trial NCT00443924). No safety issues were found. Read more at http://clinicaltrials.gov/ct2/show/study/NCT00443924?term=INS115644&rank=1.
Archive for 2010
Study of INS115644 Ophthalmic Solution in Subjects With Ocular Hypertension or Glaucoma
Wednesday, August 11th, 2010Reminder
Friday, July 16th, 2010To the many who have not updated your Bookmarks or Favorites, the web page address of ASP is now http://www.pharmacognosy.us. If you use www.phcog.org, it will forward to the current site, but this may not continue indefinitely. Please update.
Journal of Natural Products, Special Issue in Honor of John W. Daly and Richard E. Moore
Thursday, April 15th, 2010
Outstanding Contributors to the Field of Natural Product Science
| Journal of Natural Products is pleased and honored to be able to bring readers this special issue, dedicated to two extremely distinguished natural product chemists. |
2nd International Symposium on the Medicinal Plants, Their Cultivation and Aspects of Uses
Sunday, April 11th, 2010Petra Marriott Hotel, Petra, Jordan, Nov 3-4, 2010
Istodax (depsipeptide romidepsin from Chromobacterium violaceum) receives FDA approval
Wednesday, March 24th, 2010The natural product derived Istodax was approved for cutaneous T-cell lymphoma by the US FDA, November 5, 2009.
